-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
.
In this study, the researchers first modified the mutant strain of Toxoplasma gondii to have a limited growth ability, causing diseases in cultured cells or mice, but at the same time being able to manipulate the host immune system
In a mouse model, direct injection of this mutant parasite can induce an inflammatory response in the injected tumor or even in the distant tumor of the mouse
After modified Toxoplasma gondii and anti-PD-L1 treatment, the survival time of melanoma, lung cancer and colon adenocarcinoma model mice was significantly prolonged, and tumor growth was reduced
Intratumoral administration of Toxoplasma can inhibit the growth of non-injected distant tumors
The researchers said that the study confirmed the effectiveness of intratumoral injection of mutant Toxoplasma strains to improve anti-tumor immunity and checkpoint suppression therapy
In summary, intratumoral injection of mutant Toxoplasma gondii can induce systemic effects, improve the immune response of mice, sensitize immune "cold" tumors, and make mice susceptible to immune checkpoint blocking therapy
Article link: http://dx.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.